Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders	Hemic and Lymphatic Diseases, Histiocytosis, Langerhans-Cell, histiocytosis, interstitial lung disease, lung disorder, lymphatic system disorder, respiratory system disorder	Active, not recruiting	Phase 2	2026-06-23		NCT02425904

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cookies for Kids' Cancer	2
Dana-Farber Cancer Institute	324
North American Consortium for Histiocytosis	4
Sanofi	254
St. Baldrick's Foundation	8

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Arkansas Children's Hospital	Little Rock	United States	82
Boston Children's Hospital	Boston	United States	343
Children's Hospital of Los Angeles	Los Angeles	United States	56
Children's National Medical Center	Washington D.C.	United States	177
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	405
Dana-Farber Cancer Institute	Boston	United States	626
Dana-Farber Cancer Institute	Boston	United States	68
Massachusetts General Hospital	Boston	United States	1015
Mount Sinai Medical Center	New York	United States	40
Phoenix Children's Hospital	Phoenix	United States	95
St. Jude Children's Research Hospital	Memphis	United States	194
Texas Children's Hospital	Houston	United States	187
The Children's Hospital of Pennsylvania	Philadelphia	United States	1
The Hospital For Sick Children	Toronto	Canada	94
University of California San Francisco Medical Center	San Francisco	United States	10